Peter M. Moodie
Peter M. Moodie publishes mostly in Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Surgery, on topics such as Health Systems, Economic Evaluations, Quality of Life, Lipoproteins and Cardiovascular Health and Pharmaceutical Economics and Policy.
- World rank
- #4,376,954 of 7,710,434 ranked researchers
- Rank in New Zealand
- #15,132 of 21,128
- Works
- 65
- Citations
- 329
- Citations per work
- 5.1
What does Peter M. Moodie research?
Peter M. Moodie's work is mostly in Medicine (28%), Economics, Econometrics and Finance (13%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3654.9%
- Health Sciences1828.1%
- Medicine1828.1%
- Social Sciences812.6%
- Life Sciences34.4%
- 1Economics and Econometrics13% of their works
- 2Endocrinology, Diabetes and Metabolism8% of their works
- 3Surgery7% of their works
- 4Hematology7% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Molecular Biology4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Lipoproteins and Cardiovascular Health
- Pharmaceutical Economics and Policy
- Pharmaceutical industry and healthcare
- Retinoids in leukemia and cellular processes
- Acne and Rosacea Treatments and Effects
- Diabetes Treatment and Management
- Platelet Disorders and Treatments
Which keywords describe Peter M. Moodie's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Clinical Trials, Pharmaceutical Industry, Inflammation, Cholesterol-lowering, Drug Development Costs and Generic Drugs.
- Thrombosis
- Retinoic Acid
- Cardiovascular Outcomes
- Acne Vulgaris
- Conflict of Interest
- Generic Drugs
- Cholesterol-lowering
- Pharmaceutical Industry
- Quality of Life
- Cost-effectiveness Analysis
- Clinical Trials
- Inflammation
- Drug Development Costs
- Statins
- Research Outcome
- Acute Promyelocytic Leukemia
- Platelets
- Rosacea
- Type 2 Diabetes
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cost-effectiveness Analysis121 topic
- Quality of Life121 topic
- Clinical Trials92 topics
- Pharmaceutical Industry92 topics
- Inflammation62 topics
- Cholesterol-lowering51 topic
- Drug Development Costs51 topic
- Generic Drugs51 topic
- Statins51 topic
- Conflict of Interest41 topic
- Research Outcome41 topic
- Acne Vulgaris31 topic
- Acute Promyelocytic Leukemia31 topic
- Cardiovascular Outcomes31 topic
- Platelets31 topic
- Retinoic Acid31 topic
- Rosacea31 topic
- Thrombosis31 topic
- Type 2 Diabetes31 topic
Where does Peter M. Moodie work?
Peter M. Moodie's main affiliation in the publication record is Pharmac, New Zealand.
How many publications and citations does Peter M. Moodie have?
OpenAlex counts 65 works and 329 citations for Peter M. Moodie, an h-index of 10, ranking #4,376,954 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter M. Moodie. Posts are plain text and can be reported.